Development and exploration of an AI model to classify "schizophrenia with signs of relapse" and "schizophrenia with no signs of relapse" based on free conversations with medical staff

Sumitomo Pharma Co., Ltd.0 个研究点目标入组 100 人开始时间: 2022年9月13日最近更新: 2022年10月18日

适应症

试验速览

阶段: 不适用
状态: 招募中
发起方: Sumitomo Pharma Co., Ltd.
入组人数: 100
主要终点: Development and exploration of an following AI model based on free conversations with medical staff

暂无简介。

•Outpatient
•Between 18 and 65 years of age at the time of consent and diagnosed with schizophrenia according to the DSM-
•Who can obtain written consent from the person
•Who speak Japanese as his/her mother tongue and able to have an interview (conversation with doctors and medical staff)

•Who has been judged by a doctor to have difficulty in having conversation due to deafness, dysarthria, aphasia, etc.
•Who has been diagnosed of having a pyschiatric disorder such as depression
•Who has been diagnosed of a dementia or judged to have cognitive dysfunction due to neurological diseases (epilepsy, stroke, etc.)
•Who has been judged by a doctor not to be suitable for this trial by any reasons

Development and exploration of an following AI model based on free conversations with medical staff

to classify the signs of relapse for schizophrenic patient

未报告次要终点

发起方